These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3289726)

  • 1. Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma.
    Leff RS; Thompson JM; Daly MB; Johnson DB; Harden EA; Mercier RJ; Messerschmidt GL
    Cancer; 1988 Jul; 62(1):32-5. PubMed ID: 3289726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation.
    Giannone L; Wolff SN
    Cancer Treat Rep; 1987; 71(7-8):759-61. PubMed ID: 3038317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
    Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
    J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of high-dose cyclophosphamide plus high-dose etoposide in malignant brain tumors of children followed by autologous bone marrow rescue].
    Hanada R; Inaba T; Yaginuma A; Hayashi Y; Yamamoto K; Nishimoto H; Tsukiyama T
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):263-8. PubMed ID: 2645835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors.
    Kramer ED; Packer RJ; Ginsberg J; Goldman S; Thompson S; Bayer LA; Shen V; Harris R; Khan S; Finlay JL
    Pediatr Neurosurg; 1997 Nov; 27(5):230-7. PubMed ID: 9619999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
    Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
    Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors.
    Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E
    Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent brainstem gliomas treated with oral VP-16.
    Chamberlain MC
    J Neurooncol; 1993 Feb; 15(2):133-9. PubMed ID: 8509818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study.
    Balmaceda C; Fetell MR; Hesdorffer C
    Cancer Chemother Pharmacol; 1997; 40(1):72-4. PubMed ID: 9137533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
    Nakagawa H; Kubo S; Fujita T; Tsuruzono K; Miyawaki Y; Arita N; Hayakawa T
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):237-40. PubMed ID: 1736836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
    Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL
    Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracarotid VP-16 in malignant brain tumors.
    Feun LG; Lee YY; Yung WK; Savaraj N; Wallace S
    J Neurooncol; 1987; 4(4):397-401. PubMed ID: 3572470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation.
    Crump M; Brandwein JM; Scott JG; Sutcliffe SB; Keating A
    Bone Marrow Transplant; 1990 Oct; 6(4):259-61. PubMed ID: 1707701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation.
    Imrie KR; Couture F; Turner CC; Sutcliffe SB; Keating A
    Bone Marrow Transplant; 1994 Jan; 13(1):77-9. PubMed ID: 8019457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
    Santana VM; Schell MJ; Williams R; Bowman LC; Thompson EI; Brenner MK; Mirro J
    Bone Marrow Transplant; 1992 Nov; 10(5):457-62. PubMed ID: 1464010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
    Tirelli U; D'Incalci M; Canetta R; Tumolo S; Franchin G; Veronesi A; Galligioni E; Trovò MG; Rossi C; Grigoletto E
    J Clin Oncol; 1984 May; 2(5):432-7. PubMed ID: 6726296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report.
    Wolff JE; Boos J; Krähling KH; Jürgens H
    Klin Padiatr; 1996; 208(4):190-2. PubMed ID: 8776706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
    Broun ER; Nichols CR; Mandanas R; Salzman D; Turns M; Hromas R; Cornetta K; Einhorn LH
    Bone Marrow Transplant; 1995 Sep; 16(3):353-8. PubMed ID: 8535306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.